1. Home
  2. Health
  3. Colon Cancer

Journal Article: Oral CI-1040 and Advanced Colon Cancer
Cancer Research - October 2004

by Donna Myers
for About.com

Updated: August 7, 2005

About.com Health's Disease and Condition content is reviewed by the Medical Review Board

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

Journal of Clinical Oncology
JCO Early Release, published online ahead of print Oct 13 2004

John Rinehart, Alex A. Adjei, Patricia M. LoRusso, David Waterhouse, J. Randolph Hecht, Ronald B. Natale, Oday Hamid, Mary Varterasian, Peggy Asbury, Eric P. Kaldjian, Stephen Gulyas, David Y. Mitchell, Roman Herrera, Judith S. Sebolt-Leopold, and Mark B. Meyer

DOI: 10.1200/JCO.2004.01.185

Go to journal article.

Explore Colon Cancer
About.com Special Features

Learn how you can reduce your your numbers with these nutrition and exercise tips. More >

Keep yourself, and your family, happy and healthy this fall with these tips. More >

We comply with the HONcode standard for trustworthy health information: verify here.
  1. Home
  2. Health
  3. Colon Cancer
  4. Basics
  5. Research Articles
  6. Journal Article Abstracts
  7. Journal Articles from 2004
  8. Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

©2009 About.com, a part of The New York Times Company.

All rights reserved.